Favorable Decision for ACR Members in “TMA III” NSA Case
Fifth Circuit ruling on No Surprises Act QPA calculations supports fair physician reimbursement and stronger insurer accountability.
Read moreMain Content
Lead the Future of Alzheimer's Imaging — Join ALZ-NET
Oct. 2, 2025
The Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) Imaging Network, managed by the ACR Center for Research and Innovation, offers participating imaging facilities exclusive access to discounted FDA-cleared AI tools and data visualization resources— to enhance Alzheimer’s imaging workflows and patient safety.
With 41 imaging facilities already participating, another 72 in start-up, and 3,184 patients enrolled from 115 referring dementia practices nationwide, ALZ-NET supports real-world evidence generation to inform FDA safety assessments and clinical guidelines – including appropriate PET use and MR safety.
Imaging facilities are invited to contribute longitudinal brain imaging data from patients receiving FDA-approved Alzheimer’s treatments.
